Esophageal Squamous Cell Carcinoma (ESCC)

Explore clinical trials studying Esophageal Squamous Cell Carcinoma (ESCC). Study availability and eligibility vary by location and protocol.

57 public trials 22 recruiting studies

Refine in advanced search Browse all conditions

Esophageal Squamous Cell Carcinoma (ESCC) trial results

Active, Not Recruiting

Phase II Study of Induction Chemoimmunotherapy Followed by Radiotherapy and Organ Preservation in Resectable ESCC

NCT07711470

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations: National Cancer Center / Cancer Hospital, Chinese Academy of Medical Sciences Beijing, China

View Trial Details

Active, Not Recruiting

O-GlcNAcylation Induced HMGB1 Signalling

NCT07702253

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations: Department of Surgery, Faculty of Medicine, the Chinese University of Hong Kong Hong Kong

View Trial Details

Active, Not Recruiting

Predictive Biomarkers for PD-1 Inhibitor Response in Squamous Cell Carcinoma

NCT07147361

Conditions: Carcinoma, Carcinoma, Squamous Cell, Cervical Squamous Cell Carcinoma, +16 more
Locations: Department of Etiology and Carcinogenesis Beijing, Beijing Municipality, China

View Trial Details

Active, Not Recruiting

Low-Dose Radiotherapy With Retlirafusp Alfa and Chemotherapy as Neoadjuvant Therapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma

NCT07682376

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations: Harbin Medical University Cancer Hospital, No. 150 Haping Road, Nangang District, Harbin, Heilongjiang Province, China Harbin, Heilongjiang, China

View Trial Details

Active, Not Recruiting

Observational Study of Patients Treated With Nivolumab and Chemotherapy for Advanced or Metastatic Esophageal, Gastroesophageal or Gastric Cancer in France

NCT06504615

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Carcinoma, +18 more
Locations: Local Institution - 0001 Paris, France

Kappa Santé Paris, France

View Trial Details

Active, Not Recruiting

A Study of Trifluridine/Tipiracil Combined With Anlotinib as Second-line Treatment for Recurrent and Metastatic Esophageal Squamous Cell Carcinoma

NCT07142421

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations: The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Active, Not Recruiting

NCRT Combined With Sequential Perioperative PD-1 Inhibitor for LAESCC

NCT06762158

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations: Radiation Oncology Department, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Esophageal Squamous Cell Carcinoma (ESCC)

Esophageal Squamous Cell Carcinoma (ESCC) trial results

Phase II Study of Induction Chemoimmunotherapy Followed by Radiotherapy and Organ Preservation in Resectable ESCC

O-GlcNAcylation Induced HMGB1 Signalling

Predictive Biomarkers for PD-1 Inhibitor Response in Squamous Cell Carcinoma

Low-Dose Radiotherapy With Retlirafusp Alfa and Chemotherapy as Neoadjuvant Therapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma

Observational Study of Patients Treated With Nivolumab and Chemotherapy for Advanced or Metastatic Esophageal, Gastroesophageal or Gastric Cancer in France

A Study of Trifluridine/Tipiracil Combined With Anlotinib as Second-line Treatment for Recurrent and Metastatic Esophageal Squamous Cell Carcinoma

NCRT Combined With Sequential Perioperative PD-1 Inhibitor for LAESCC

Related conditions